Clinical significance of urinary glycosaminoglycan excretion in inflammatory bowel disease patients

• Autorzy: Derkacz A. , Olczyk P. , Jura-Poltorak A. , Waluga-Kozlowska E. , Olczyk K. , Komosinska-Vassev K.
• Języki publikacji: EN

Abstrakty

EN

Słowa kluczowe

EN

inflammatory bowel disease; glycosaminoglycan; urinary excretion; Crohn's disease; ulcerative colitis; chondroitin sulphate; patient

• Wydawca: -
• Czasopismo: Journal of Physiology and Pharmacology
• Rocznik: 2020
• Tom: 71
• Numer: 6
• Opis fizyczny: p.793-801,fig.,ref.

Twórcy

autor

Derkacz A.

• Departament of Clinical Chemistry and Laboratory Diagnostics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Sosnowiec, Poland

autor

Olczyk P.

• Departament of Community Pharmacy, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Sosnowiec, Poland

autor

Jura-Poltorak A.

• Departament of Clinical Chemistry and Laboratory Diagnostics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Sosnowiec, Poland

autor

Waluga-Kozlowska E.

• Departament of Community Pharmacy, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Sosnowiec, Poland

autor

Olczyk K.

• Departament of Clinical Chemistry and Laboratory Diagnostics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Sosnowiec, Poland

autor

Komosinska-Vassev K.

• Departament of Clinical Chemistry and Laboratory Diagnostics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Sosnowiec, Poland

Identyfikatory

DOI

10.26402/jpp.2020.6.03